Common Side Effects vs Serious Concerns When discussing GLP-1 side effects, its important to distinguish between common, manageable side effects and rare, serious concerns
Nassar M, Misra A, Bloomgarden Z (2024) Impact of treatment with GLP-1RAs on suicide attempts in adults persons with type 2 diabetes: a retrospective comparative effectiveness study based on a global TriNetX health research database
According to FDA-approved labeling and American Diabetes Association guidelines, these medications have demonstrated significant benefits in reducing hemoglobin A1c levels and promoting clinically meaningful weight loss
Eliminating or reducing coffee during this critical adjustment window can significantly improve tolerability
In Phase 2 trials, Retatrutide produced weight loss of up to 24.2% of body weight over 48 weeks
Tirzepatide Tirzepatide is a dual agonist, meaning it acts as both a GLP-1 and GIP receptor agonist